Harvard Bioscience Inc
NASDAQ:HBIO
Harvard Bioscience Inc
NASDAQ:HBIO
Price:
3.85 USD
0.79%
Market Closed
Updated:
May 6, 2024
Harvard Bioscience Inc
Cash from Operating Activities
|
Harvard Bioscience Inc
Cash from Operating Activities Peer Comparison
Comparables:
TMO
DHR
WST
A
IQV
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Harvard Bioscience Inc
NASDAQ:HBIO
|
Cash from Operating Activities
$14m
|
CAGR 3-Years
15%
|
CAGR 5-Years
37%
|
CAGR 10-Years
13%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash from Operating Activities
$8.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
|
|
Danaher Corp
NYSE:DHR
|
Cash from Operating Activities
$7B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
12%
|
CAGR 10-Years
7%
|
|
|
West Pharmaceutical Services Inc
NYSE:WST
|
Cash from Operating Activities
$756.6m
|
CAGR 3-Years
14%
|
CAGR 5-Years
21%
|
CAGR 10-Years
14%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Cash from Operating Activities
$2B
|
CAGR 3-Years
17%
|
CAGR 5-Years
13%
|
CAGR 10-Years
6%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cash from Operating Activities
$2.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
11%
|
CAGR 10-Years
19%
|
See Also
What is Harvard Bioscience Inc's Cash from Operating Activities?
Cash from Operating Activities
14m
USD
14m
USD
Based on the financial report for Dec 31, 2023, Harvard Bioscience Inc's Cash from Operating Activities amounts to 14m USD.
What is Harvard Bioscience Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
13%
13%
Over the last year, the Cash from Operating Activities growth was 1 120%. The average annual Cash from Operating Activities growth rates for Harvard Bioscience Inc have been 15% over the past three years , 37% over the past five years , and 13% over the past ten years .
You don't have any saved screeners yet
